September 1, 2022
1 minute read
Porter does not report related financial disclosures. See research for relevant financial disclosures of all other authors.
Results from the study show that people with psoriasis want cheaper oral and topical medications and want to explore more nonpharmacologic options to treat their condition.
“Psoriasis can have a significant impact on a patient’s quality of life. ” Caroline Porter, MD Written by a professor of dermatology at Wake Forest University School of Medicine and a colleague. “Although the introduction of new therapies has improved treatment outcomes, treatment gaps may still exist.”
In the current analysis, Porter and colleagues surveyed 417 patients who had Amazon Mechanical Turk accounts. She in the cohort was 51.1% female and 39.3% were between her 31 and her 40 years of age.
Mild disease was reported in 61.2%, while 25.4% had moderate psoriasis and 13.4% had severe disease.
Nearly three-quarters (74.8%) of patients were currently receiving psoriasis treatment.
51.6% of the cohort reported being satisfied with their current treatment regimen, while 24.5% reported being slightly or not at all satisfied.
Satisfaction with topical therapy was 59.5%, oral therapy 46%, and injection therapy 19.9%.
In addition, 78.7% of the cohort felt slightly or strongly that more cost-effective options should be available.
For example, patients suggested that access to UV phototherapy could be improved. In addition, we welcome further research on diet, exercise, stress reduction, and other lifestyle interventions.
Researchers say their findings are limited by the need for an Amazon account.
“A gap in current psoriasis treatment options includes more affordable topical and oral treatments that work faster and require less frequent use,” the researchers concluded. “Despite advances in psoriasis treatment, there remains a need for more effective, faster, longer-acting, less expensive and more accessible treatments.”